MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 381 to 400 of 166,322 approvalsPage 20 of 8317

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20254146
Registration: May 13, 2025

Progesterone Soft Capsules

Approval Number: 国药准字H20254091
Registration: May 13, 2025

Norepinephrine Bitartrate Injection

Approval Number: 国药准字H20254158
Registration: May 13, 2025

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20254080
Registration: May 13, 2025

Hydrocodone Bitartrate and Ibuprofen Tablets

Approval Number: 国药准字H20254118
Registration: May 13, 2025

Minoxidil Liniment

Approval Number: 国药准字H20254134
Registration: May 13, 2025

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20254078
Registration: May 13, 2025

Roxadustat Capsules

Approval Number: 国药准字H20254104
Registration: May 13, 2025

Calcium Chloride Injection

Approval Number: 国药准字H20254084
Registration: May 13, 2025

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254141
Registration: May 13, 2025

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254161
Registration: May 13, 2025

Gabexate Mesylate for Injection

Approval Number: 国药准字H20254110
Registration: May 13, 2025

Dronedarone Hydrochloride Tablets

Approval Number: 国药准字H20254075
Registration: May 13, 2025

Tobramycin Eye Drops

Approval Number: 国药准字H20254153
Registration: May 13, 2025

Isoniazid Injection

Approval Number: 国药准字H20254123
Registration: May 13, 2025

Acetylcysteine Solution for Inhalation

Approval Number: 国药准字H20254128
Registration: May 13, 2025

Iopromide Injection

Approval Number: 国药准字H20254086
Registration: May 13, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.